Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations
2024

Current Operating Procedure for Bleomycin ElectroScleroTherapy of Low-Flow Vascular Malformations

publication Evidence: moderate

Author Information

Author(s): Tobian Muir, Wohlgemuth Walter A, Cemazar Maja, Bertino Giulia, Groselj Ales, Ratnam Lakshmi A, McCafferty Ian, Wildgruber Moritz, Gebauer Bernhard, de Terlizzi Francesca, Zanasi Alessandro, Sersa Gregor

Hypothesis

Bleomycin ElectroScleroTherapy (BEST) can enhance the treatment of low-flow vascular malformations.

Conclusion

The proposed Current Operating Procedure standardizes the use of BEST for treating low-flow vascular malformations.

Supporting Evidence

  • BEST is a new approach that combines bleomycin with electric pulses to treat vascular malformations.
  • The procedure aims to standardize treatment for low-flow vascular malformations.
  • Clinical reports suggest that BEST can reduce the number of treatments needed compared to conventional methods.

Takeaway

This study explains how doctors can use a special treatment called BEST to help kids and adults with certain blood vessel problems.

Methodology

The study outlines a protocol for using Bleomycin ElectroScleroTherapy, including patient selection, treatment procedures, and safety measures.

Limitations

The procedure is based on the experience of a few centers, and further research is needed to establish optimal dosages and treatment intervals.

Digital Object Identifier (DOI)

10.2478/raon-2024-0061

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication